🇺🇸 FDA

Company profile · Sponsor

Akari

Akari Therapeutics Plc

AKTX · NYSE pharma TAMPA, FL, USA
Pipeline
9
Drugs
0
Patents
0

Quick answer

Akari (AKTX) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker AKTX
Exchange NYSE
Company type pharma
Headquarters TAMPA, FL, USA
SEC CIK 0001541157

Pipeline (9)

Search pipeline →

  1. nomacopan (rVA576)

    Akari

    Bullous Pemphigoid

    phase 3 small molecule terminated

    1 trial

  2. nomacopan (rVA576)

    Akari

    Thrombotic Microangiopathies

    phase 3 small molecule terminated

    1 trial

  3. rVA576

    Akari

    Paroxysmal Nocturnal Hemoglobinuria (PNH)

    phase 3 small molecule completed

    1 trial

  4. rVA576

    Akari

    Paroxysmal Nocturnal Hemoglobinuria

    phase 3 small molecule terminated

    1 trial

  5. Coversin

    Akari

    Paroxysmal Nocturnal Hemoglobinuria (PNH)

    phase 2 small molecule completed

    1 trial

  6. Coversin

    Akari

    Paroxysmal Nocturnal Haemoglobinuria (PNH)

    phase 2 small molecule completed

    1 trial

  7. MRX-6

    Akari

    Atopic Dermatitis

    phase 2 small molecule terminated

    1 trial

  8. rVA576

    Akari

    Bullous Pemphigoid (BP)

    phase 2 small molecule completed

    1 trial

  9. rVA576

    Akari

    Keratoconjunctivitis, Atopic

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is Akari?

Akari (AKTX) is a pharma company. headquartered in TAMPA, FL, USA. listed on NYSE. NovaPharmaNews links 9 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Akari sponsor?

We track 9 ClinicalTrials.gov-linked programs for Akari, including nomacopan (rVA576) and 8 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Akari company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.